THE TREATMENT OF SHOCK ACCOMPANYING MYOCARDIAL INFARCTION
- Medication Adherence After Myocardial Infarction: A Long Way Left To Go. Choudhry, Niteesh K.; Winkelmayer, Wolfgang C. // JGIM: Journal of General Internal Medicine;Feb2008, Vol. 23 Issue 2, p216
The author reflects on the developments surrounding the medication for the treatment and prevention of myocardial infarction. The medications of coronary heart disease have been subject to various evaluation in trials. Several drugs, which are taken in combination, have been estimated to reduce...
- Primary angioplasty should be first line treatment for acute myocardial infarction. Smith, David; Channer, Kevin // BMJ: British Medical Journal (International Edition);5/22/2004, Vol. 328 Issue 7450, p1254
Presents a medical debate regarding primary angioplasty as a first line treatment for acute myocardial infarction. Relation between normal coronary artery blood flow and mortality after myocardial infarction; Comparison of the methods thrombolysis and coronary angioplasty for restoring blood flow.
- In-hospital outcomes after primary percutaneous coronary intervention according to left ventricular ejection fraction. Vakili, Hossein; Sadeghi, Roxana; Rezapoor, Parisa; Gachkar, Latif // ARYA Atherosclerosis;2014, Vol. 10 Issue 4, p1
BACKGROUND: The primary objective of primary percutaneous coronary intervention (pPCI) in patients with acute ST-segment elevation myocardial infarction (STEMI) is not only to restore the blood flow in the infarct-related artery, but also to save the patients' quality and duration of their life....
- The heart of the matter. Rosser, Maria // Emergency Nurse;Dec2008, Vol. 16 Issue 8, p22
The article explains why primary percutaneous coronary intervention (PPCI) is preferable to thrombolysis as a treatment for patients with acute myocardial infarction (AMI). The key aim of either therapy is the effective restoration of the blood supply to myocardial muscle. In thrombolysis,...
- Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing. Kempf, Tibor; Zarbock, Alexander; Vestweber, Dietmar; Wollert, Kai // Journal of Molecular Medicine;Apr2012, Vol. 90 Issue 4, p361
The wound healing response after myocardial infarction (MI) involves a cascade of molecular and cellular events that lead to a replacement of the necrotic area with a collagen-rich scar. Clearance of necrotic debris by neutrophils, monocytes, and macrophages is a critical component of infarct...
- Guidelines-based treatments benefit elderly with MI. // PharmacoEconomics & Outcomes News;6/13/2009, Issue 580, p6
The article discusses research being done on the use of guidelines-recommended treatments in the clinical management of myocardial infarction (MI) in elderly patients. It references a study by F. Schiele and colleagues, published in the April 2009 issue of the "European Heart Journal." The study...
- Efficacy of Eplerenone for Treatment of Heart Failure. Zepf, Bill // American Family Physician;12/1/2003, Vol. 68 Issue 11, p2256
Presents an abstract of the study "Eplerenone, a Selective Aldosterone Blocker, in Patients With Left Ventricular Dysfunction After Myocardial Infarction," by B. Pitt et al., from the April 3, 2003 issue of the "New England Journal of Medicine."
- Reperfusion Therapy for Acute Myocardial Infarction: Which Strategy for Which Patient? Boersma, E.; Steyerberg, E.W.; van der Vlugt, M.J.; Simoons, M.L. // Drugs;Jul1998, Vol. 56 Issue 1, p31
Several modes of reperfusion therapy for evolving myocardial infarction (MI) have been developed, which differ in terms of effectiveness, complexity and costs. Reperfusion resources are often restricted by budgetary or logistical circumstances. To arrive at an equitable distribution of treatment...
- Stopping aspirin raises CVD mortality risk. // Pulse;8/10/2011, Vol. 71 Issue 26, p8
The article reports that Spanish researchers have found that cessation of aspirin use as secondary prevention for cardiovascular disease can increase the risk of heart attack or coronary heart disease by 50%.